YaJun Mao

Dr. YaJun Mao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
HYHang Yang
Hang Yang
ZLZhenyi Liao
Zhenyi Liao
YZYe Zhou
Ye Zhou
ZGZhenzhen Gao
Zhenzhen Gao
YMYaJun Mao
YaJun Mao
Background: Inflammation and liver function are associated with cognitive decline and dementia. Little is known about the serum albumin-to-globulin ratio on cognitive function.Objective: The objective of this study was to investigate the association between albumin-to-globulin ratio and cognitive function among the American older people.Methods: The public data available on the US National Health and Nutrition Examination Survey (NHANES) from 2011 to 2014 was used for this cross-sectional study. Participants aged ≥60 years completed the cognitive function assessments, including word learning and recall modules from the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), the animal fluency (AF) test, and the digit symbol substitution test (DSST). A composite cognition score was calculated to evaluate global cognition. The univariate and multivariate linear regression analysis, curve fitting, a threshold effect, along with a subgroup analysis and interaction tests were conducted.Results: Serum albumin-to-globulin ratio (per 0.1 unit) was positively associated DSST score (β = 0.36, 95% CI: 0.21, 0.51), AF score (β = 0.1, 95% CI: 0.04, 0.16) and global cognition score (β = 0.05, 95% CI: 0.02, 0.07), after being fully adjusted, while albumin-to-globulin ratio was not related to CERAD score (β = 0.05, 95% CI: −0.02, 0.12). A non-linear was observed in the dose–response relationship between albumin-to-globulin ratio and global cognition (P for non-linearity < 0.001). The subgroup analysis was overall stable, yet the interaction test was significant for age on global cognition (P for interaction = 0.036).Conclusion: The findings of this cross-sectional study suggested a positive and non-linear association between albumin-to-globulin ratio and cognitive function in the American older people. Maintaining albumin-to-globulin ratio with an appropriate range may be one of the therapeutic strategies to limit the progression of cognitive decline for the older people.

1 January 2024 in International Journal for Quality in Health Care
Verified
Journal Article
Closed access
PDF file
HYHang Yang
Hang Yang
ZGZhenzhen Gao
Zhenzhen Gao
YZYe Zhou
Ye Zhou
ZLZhenyi Liao
Zhenyi Liao
CSCaiping Song
Caiping Song
YMYaJun Mao
YaJun Mao
Background: Gait adaptability is essential for stroke survivors to achieve efficient and safe community ambulation. However, conventional treadmill rehabilitation is only a repetitive practice of leg movement. This study compared the effects of augmented reality (AR) treadmill-based gait adaptation training with regular treadmill programs for patients with stroke. Methods: Forty patients with stroke (N = 40) were randomly assigned to the gait adaptation training (n = 20, age: 49.85 (SD 8.44) years; onset of stroke: 107.80 (SD 48.31) days) and regular training (n = 20, age: 50.75 (SD 8.05) years, onset of stroke: 111.60 (SD 49.62) days) groups. Both groups completed three sessions of training per week for five weeks (15 sessions). The primary outcomes were the 10-meter walk test, and success rate of obstacle avoidance, while secondary outcomes included the Berg balance scale, component timed-up-and-go, and fall rate in a six-month follow-up period. Assessments were performed before and after the intervention. The paired t-test was applied to compare the differences within groups and independent sample t-test was performed to compare the differences between groups. Results: The 10-meter walk test, success rate of obstacle avoidance, Berg balance scale, component timed-up-and-go all significantly improved in both groups (P < 0.001). The success rate of obstacle avoidance (P = 0.02, 95% CI: -21.07, -1.64), Berg Balance Scale (P = 0.02, 95% CI: -8.03, -0.67), “turning around time” (P = 0.04, 95% CI: 0.08, 2.81), “stand-to-sit” (P = 0.03, 95% CI: 0.16, 2.41) and “total time” (P = 0.048, 95% CI: 0.04, 10.32) improved significantly in gait adaptation training group after intervention, while the 10-meter walk test (P = 0.09, 95% CI: -0.17, 0.01), timed “sit-to-stand” (P = 0.09, 95% CI: -0.14, 2.04) and “linear walking” (P = 0.09, 95% CI: -0.27, 3.25) in gait adaptation training group didn’t show statistical difference compared to the regular training group. Total fall rate during the follow-up period was statistically decreased in the gait adaptation training group (P = 0.045). Conclusions: Both interventions improved mobility outcomes, with AR treadmill-based gait adaptation indicating greater improvement in obstacle avoidance, balance, turning, and stand-to-sit. AR treadmill-based gait adaptation training emerges as an effective and promising intervention for patients with stroke in early rehabilitation.

24 June 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
WJWenjie Jin
Wenjie Jin
XNXuekang Niu
Xuekang Niu
YLYanlin Liu
Yanlin Liu
ZZZhiwen Zhu
Zhiwen Zhu
ZGZhenzhen Gao
Zhenzhen Gao
YMYaJun Mao
YaJun Mao
Background: Closed-loop motor imagery brain-computer interface (MI-BCI) training may support post-stroke upper-limb rehabilitation by coupling motor intention with contingent multisensory feedback. This randomized pilot trial examined its feasibility, safety, short-term clinical effects, and exploratory EEG correlates in patients with subacute stroke. Methods: In this single-center, assessor-blinded, two-arm pilot trial, 40 patients with first-ever subcortical stroke in the subacute phase were randomized 1:1 to a BCI group or an active control group after a 2-day motor imagery familiarization phase. Both groups received routine medical management, standardized conventional rehabilitation, and dose-matched motor imagery-based hand training for 4 weeks. The BCI group received EEG-contingent closed-loop MI-BCI-assisted training with a soft rehabilitation glove, whereas the control group received non-EEG-contingent glove-assisted motor imagery training under matched training duration, task instructions, device exposure, and multisensory feedback. The primary outcome was the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE). Secondary outcomes included the Action Research Arm Test (ARAT) and Modified Barthel Index (MBI). Exploratory EEG outcomes included FFT%α and FFT%β during motor imagery. Clinical and EEG outcomes were analyzed using baseline-adjusted ANCOVA models, with week-4 values as dependent variables and corresponding baseline values as covariates. Results: All randomized participants completed the 4-week assessment. In baseline-adjusted ANCOVA models, the BCI group showed higher week-4 scores than the control group for FMA-UE (adjusted mean difference, 13.40 points; 95% CI, 10.71–16.08; p < 0.001), ARAT (7.31 points; 95% CI, 4.55–10.07; p < 0.001), and MBI (12.21 points; 95% CI, 8.55–15.87; p < 0.001). Exploratory EEG analyses also showed higher week-4 FFT%α and FFT%β in the BCI group, with adjusted mean differences of 6.78 percentage points (95% CI, 5.22–8.34; p < 0.001) and 3.95 percentage points (95% CI, 2.53–5.36; p < 0.001), respectively. No serious adverse events occurred. Conclusion: Closed-loop MI-BCI-assisted training was feasible and well tolerated in selected patients with subacute stroke. The observed short-term improvements in upper-limb impairment and activity capacity provide preliminary signals of potential benefit beyond dose-matched non-EEG-contingent feedback training. Exploratory EEG findings suggest task-related modulation of alpha- and beta-band sensorimotor rhythmic activity, but should be interpreted as hypothesis-generating rather than confirmatory evidence of neural reorganization. Larger multicenter trials with longer follow-up, rigorous neurophysiological analyses, and real-world upper-limb use outcomes are needed. Clinical Trial Registration: ChiCTR2400083992. https://www.chictr.org.cn/showproj.html?proj=229529